Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

AstraZeneca Halts £200m Research Investment in Cambridge

Summary by BizToc
The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

pharmaceutical-technology.compharmaceutical-technology.com
Reposted by
BizTocBizToc

AstraZeneca halts £200m research investment in Cambridge

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from Reuters.

Read Full Article
negocios.comnegocios.com

Astrazeneca Cancels Its 270 Million Research Center in Cambridge and Spain Dreams of Keeping It

The pharmaceutical company AstraZeneca , one of the protagonists in the race for vaccines against the COVID-19, has cancelled its expansion plan in the United Kingdom. The company has decided to stop the construction of a new center of...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

negocios.com broke the news in on Sunday, September 14, 2025.
Sources are mostly out of (0)

Similar News Topics

AstraZeneca icon

AstraZeneca

Vaccines icon

Vaccines

Coronavirus icon

Coronavirus

England icon

England

News
For You
SearchBlindspotLocal